A potential sale of DePuy Synthes for about US$20b has put Johnson & Johnson (JNJ) back in focus for investors watching how ...
Executive Vice President and Chief Financial Officer Joe Wolk said the company sees a path to growth above its previously ...
Johnson & Johnson does not provide GAAP financial measures on a forward-looking basis because the company is unable to predict with reasonable certainty the ultimate outcome of legal proceedings, ...
Monday - Friday, 6:00 - 7:00 PM ET As Wall Street navigates a jam-packed start to earnings season, CNBC's Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its ...
Add Yahoo as a preferred source to see more of our stories on Google. On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked ...
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson’s JNJ IMAAVY (nipocalimab-aahu) to treat warm autoimmune hemolytic anemia (wAIHA). The agency cleared the medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results